NovoCure Limited (NVCR) Total liabilities 2017–2026
NovoCure Limited (NVCR) total liabilities at each fiscal year-end, per SEC filings.
$463.9MFY2026 · since FY2017: $139.7M → $463.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $463.9M | -47.3% |
| FY2025 | $880.6M | +12.4% |
| FY2024 | $783.6M | +4.4% |
| FY2023 | $750.5M | +2.9% |
| FY2022 | $729.0M | +26.7% |
| FY2021 | $575.5M | +119.9% |
| FY2020 | $261.7M | +15.0% |
| FY2019 | $227.5M | +50.0% |
| FY2018 | $151.7M | +8.6% |
| FY2017 | $139.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice